The fourth-generation EGFR TKI BDTX-1535 yielded robust clinical activity and durability in patients with relapsed/refractory, EGFR-mutant non–small cell lung cancer (NSCLC) harboring classical, non-classical,...
The US Food and Drug Administration (FDA) is poised to regulate a "potential first-in-class antipsychotic", known as KarXT, said Medscape.About one in 300 people...
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals...